Gene Mutation May Explain Why Some Don’t Get Sick from COVID-19
A common mutation can help people infected with the COVID-19 virus avoid developing any symptoms.
University of California San Francisco
Give to UCSFA common mutation can help people infected with the COVID-19 virus avoid developing any symptoms.
Improving predictive models with artificial intelligence may help advance diagnostics for heart disease and limit invasive testing with catheters that can be risky, especially for patients already experiencing heart and stroke issues.
In this Q&A, UCSF experts offer tips on how to stay protected during heat waves, and how to be aware of treat heat-related illnesses.
A new Alzheimer’s drug is expected to be approved by the Food and Drug Administration (FDA). However, the medication works best mostly for those in the earliest stages of Alzheimer’s.
Deaths among older adults with dementia fell starkly in nursing homes and long-term care centers after COVID-19 vaccinations became available, but remained high for those living at home.
A short course of antibiotics, Doxy-PEP, can prevent some STIs after condomless sex.
A rare burst of visual creativity is seen occasionally in patients with frontotemporal dementia. A UCSF-led study offers new insights into how this talent develops as key areas of the brain degenerate.
UCSF is helping to create the first large group of Asian American study participants to help improve Alzheimer’s disease care for the Asian community North America.
A large, collaborative study on multiple sclerosis (MS) severity found that a single gene variant is predictive of much faster neurodegeneration in MS patients.
UCSF is one of four U.S. hospitals to be verified as part of the ACS Vascular Verification Program.
In the wake of long wait times and overcrowding in California emergency departments, emergency visits grew by 23% while the number of emergency departemtns and hospital beds declined.
UCSF primary care physician and researcher Alka M. Kanaya, MD, is being recognized with the 2023 Kelly West Award for Outstanding Achievement in Epidemiology from the American Diabetes Association (ADA).
UCSF Benioff Homelessness and Housing Initiative has released the largest study of homelessness in the United States since the mid-1990s, providing a thorough look at the causes, consequences, and potential policy changes of homelessness in California.
UCSF infectious disease specialist Michael Peluso, MD, who co-leads one of the world’s oldest studies of long COVID, discusses the condition’s mysteries.
UCSF’s Nevan Krogan, PhD, is taking aim at the world’s deadliest diseases by uniting scientists and the biomedical industry to speed treatments.
The advent of cheap, easy-to-use blood tests for Alzheimer’s disease has the potential to revolutionize diagnosis and treatment. But they also raise difficult questions that the field is only beginning to consider.
Engineered immune cells. Supercharged scans. Drug implants. Gene manipulators. Blood biopsies. Read how these breakthroughs are transforming cancer care.
A new treatment approach draws on research into the unique teenage brain.
Quantitative Biosciences Institute’s Nevan Krogan reflects back on the COVID-19 pandemic and how internal and external communications, funding and international partnerships all contributed to a speedy COVID-19 response.
Two UCSF scientists – James Gardner, MD, PhD, and Rebeca de Pavia Fróes Rocha, PhD – have received Pew awards for their work in immunology as part of a program that supports promising early-career investigators.
Two new oral polio vaccines will help limit the amount of new polio strains and outbreaks by genetically engineering weakened polio virus in the oral vaccine to reduce reversion to dangerous forms.